ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,849.91
0.23%
Dow Jones
42,470.32
0.41%
US Dollar vs MXN
20.51858
-0.47%
Brent Oil
79.70
-0.72%
Bitcoin
96,583.92
2.19%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Cartesian Therapeutics Inc (RNAC) Cotización

Cartesian Therapeutics Inc

Cartesian Therapeutics Inc (RNAC)

NASDAQ
18.53
0.20
( 1.09% )
Actualizado: 09:22:13
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
18.53
Postura de Compra
18.20
Postura de Venta
18.49
Volume Operado de la Acción
4,765
18.21 Rango del Día 18.77
11.665 Rango de 52 semanas 41.87
Capitalización de Mercado [m]
470.938M
Precio Anterior
18.33
Precio de Apertura
18.28
Hora
13
@
18.39
Última hora de negociación
09:25:29
Volumen financiero
US$ 87,435
Precio Promedio Ponderado
18.3495
Volumen promedio (3 m)
126,619
Acciones en circulación
25,414,898
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.12
Beneficio por acción (BPA)
-8.64
turnover
26M
Beneficio neto
-219.71M

Acerca de Cartesian Therapeutics Inc

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL... Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.selectabio.com
Sede
Wilmington, Delaware, USA
Fundado
-
Cartesian Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RNAC. The last closing price for Cartesian Therapeutics was US$18.33. Over the last year, Cartesian Therapeutics shares have traded in a share price range of US$ 11.665 to US$ 41.87.

Cartesian Therapeutics currently has 25,414,898 shares in issue. The market capitalisation of Cartesian Therapeutics is US$465.86 million. Cartesian Therapeutics has a price to earnings ratio (PE ratio) of -2.12.

RNAC Últimas noticias

Más noticias

Form EFFECT - Notice of Effectiveness

10 horas hace
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

10 horas hace
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

19 horas hace
Edgar (US Regulatory)

Cartesian Therapeutics Highlights Progress and 2025 Strategic Priorities Across Pipeline of mRNA Cell Therapies for Autoimmune Diseases

Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25 Deepening responses observed over time in Descartes-08-treated participants in Phase 2b trial in myasthenia...

13 Enero 2025
GlobeNewswire Inc.

Form POS AM - Post-Effective amendments for registration statement

10 Enero 2025
Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement

10 Enero 2025
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

09 Enero 2025
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

09 Enero 2025
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

09 Enero 2025
Edgar (US Regulatory)

Form 424B7 - Prospectus [Rule 424(b)(7)]

08 Enero 2025
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.724.0426726558117.8118.7716.411982417.25451188CS
4-0.45-2.3709167544818.9820.29516.415541118.21293857CS
12-3.7-16.644174538922.2326.515.512661919.2163058CS
261.156.616800920617.3826.512.4811252018.29602821CS
52-5.47-22.79166666672441.8711.66524574319.92769705CS
156-5.665-23.413928497624.19542.611.66536293522.6123651CS
260-5.665-23.413928497624.19542.611.66536293522.6123651CS

RNAC - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Cartesian Therapeutics?
El precio actual de las acciones de Cartesian Therapeutics es US$ 18.53
¿Cuántas acciones de Cartesian Therapeutics están en circulación?
Cartesian Therapeutics tiene 25,414,898 acciones en circulación
¿Cuál es la capitalización de mercado de Cartesian Therapeutics?
La capitalización de mercado de Cartesian Therapeutics es USD 465.86M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Cartesian Therapeutics?
Cartesian Therapeutics ha negociado en un rango de US$ 11.665 a US$ 41.87 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Cartesian Therapeutics?
El ratio precio/beneficio de Cartesian Therapeutics es -2.12
¿Cuál es el ratio de efectivo a ventas de Cartesian Therapeutics?
El ratio de efectivo a ventas de Cartesian Therapeutics es 17.91
¿Cuál es la moneda de reporte de Cartesian Therapeutics?
Cartesian Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Cartesian Therapeutics?
El último ingresos anual de Cartesian Therapeutics es USD 26M
¿Cuál es el último beneficio anual de Cartesian Therapeutics?
El último beneficio anual de Cartesian Therapeutics es USD -219.71M
¿Cuál es la dirección registrada de Cartesian Therapeutics?
La dirección registrada de Cartesian Therapeutics es CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Cartesian Therapeutics?
La dirección del sitio web de Cartesian Therapeutics es www.selectabio.com
¿En qué sector industrial opera Cartesian Therapeutics?
Cartesian Therapeutics opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ERNAEterna Therapeutics Inc
US$ 0.8992
(191.00%)
289.69M
NMHINatures Miracle Holding Inc
US$ 3.07
(171.68%)
121.82M
AIFFFirefly Neuroscience Inc
US$ 4.21
(121.58%)
94.2M
HEESH and E Equipment Services Inc
US$ 90.405
(105.75%)
5.6M
TDUPThredUp Inc
US$ 1.8807
(44.67%)
7.12M
PHIOPhio Pharmaceuticals Corporation
US$ 4.0499
(-38.64%)
6.76M
MBIOMustang Bio Inc
US$ 0.15255
(-31.87%)
7.66M
ATPCAgape ATP Corporation
US$ 1.3699
(-30.46%)
706.29k
AVGRAvinger Inc
US$ 0.5783
(-27.99%)
904.27k
SLRXSalarius Pharmaceuticals Inc
US$ 2.65
(-27.79%)
998.87k
ERNAEterna Therapeutics Inc
US$ 0.8999
(191.23%)
289.8M
NMHINatures Miracle Holding Inc
US$ 3.0717
(171.83%)
121.82M
RGTIRigetti Computing Inc
US$ 8.0615
(33.25%)
101.72M
AIFFFirefly Neuroscience Inc
US$ 4.1842
(120.22%)
94.24M
PIIIP3 Partners Inc
US$ 0.271
(26.11%)
64.72M

Discusión

Ver feed completo
RobotDroid RobotDroid 3 minutos hace
2025 and the neverending grift goes on and on. Mute inept nonmanagement is hiding some bad truths from SH by their self imposed silence.
NWBO
2H2 2H2 3 minutos hace
5930 SPX would be short zone for me, if we even get there.
UVIX
Propain Propain 3 minutos hace
yes, through Schwab. Rumble wants to buy your shares at $7.50 per share.
RUM
John Doe 2024 John Doe 2024 3 minutos hace
He thought is was going to be but it failed multiple attempts. That is why they had to pivot to these nano coatings they are pushing now to hope that's the soultion.
XERI
AlwaysOptimistic AlwaysOptimistic 4 minutos hace
Is Quantum Computing # 26?

25 Everyday Inventions You Didn’t Know Came from Military Innovations

https://thenatureofhome.com/military-inventions-we-use-everyday/
IONQ
just4fun2 just4fun2 4 minutos hace
This is just getting started!! This is 0.05 easy!!! Imo 🚀🚀🚀💰💰💰💰🚨🚨🚨🚨
RDAR
europa7 europa7 4 minutos hace
Launch of SpaceX Falcon 9 with Transporter 12
Date: January 14, 2025 18:30 – 20:00 UTC
Venue: Vandenberg Space Force Base, California
OFFICIAL SPACEX LIVE STREAM
https://www.spacetv.net/live/launch-of-spacex-falcon-9-with-transporter-12/

posted for those sa
LAES
DewDiligence DewDiligence 4 minutos hace
Scam alert:

https://www.businesswire.com/news/home/20250113134838/en Olfactive Biosolutions uses proprietary formulations of food molecules to activate ectopic receptors in the body, replacing pharmaceuticals and treating myriad diseases.

This approach promises the ab
GLP
bunda bunda 4 minutos hace
News out
IGPK
PROPHET-of-PROFITS PROPHET-of-PROFITS 4 minutos hace
they have more news in the back pocket because 500m is still to be canceled.
RDAR
dstock07734 dstock07734 4 minutos hace
FeMike,

I don't know if MHRA will grant the approval news this month since UK has been enthusiastic about all those mRNA stuff. The massive trial of enrolling 10 patients was supposed to start in 2026. But they jump started the end of 2023 while BNTX can only provide the neo-peptide v
BNTX NWBO
bigworld bigworld 4 minutos hace
gfp: We may get a little relief rally heading toward Inauguration Day. But I see too many headwinds. Even with the phony inflation numbers the government is conjuring up. The 10 Year is still flirting with 4.8%. The leaders of the markets in recent years are showing signs of stress. I want UVXY to d
UVXY
tunnelvisionofplenty tunnelvisionofplenty 4 minutos hace
As Flipper and others pointed out, the quotes you cited are not even close to representative of what most companies are doing.

Heck, the quotes from Nymox are not even representative of what Nymox is doing. Sure, in July of 2024 they included one line in one PR in which they promised
NWBO
ProfitChaser ProfitChaser 5 minutos hace
NIce. Added a good bit yesterday at 0011
RickNagra RickNagra 5 minutos hace
Are there any gaps below us that need to be filled ?  Any gappers out there ?
FNMA
TrendTrade2016 TrendTrade2016 5 minutos hace
Here comes the RS campaign in the otc
VNTA
Trooperstocks Trooperstocks 5 minutos hace
Unlock Cutting-Edge Soil Carbon Capture Updates - Join Our Thrilling Expedition!" $SGTM

https://img1.wsimg.com/isteam/stock/7881/:/cr=t:0%25,l:8.33%25,w:83.33%25,h:100%25/rs=w:1200,cg:true
SGTM
bunda bunda 5 minutos hace
Bhat need a shower
BHAT
Paulie Pennies Paulie Pennies 5 minutos hace
$ASII Everyone is busy today watching Pete Hegseth mop the floor with Jack Reed et al. 😎
ASII
quester614 quester614 5 minutos hace
In reality it is the PROOF that you LOST our first bet because XERI never received any XTI shares only CASH. let alone the second where you bet Nexboard would be certified in 2023
XERI
AJH92 AJH92 5 minutos hace
Perhaps the clown shouldn't have tried making out that $PSRU wasn't a real, profitable company with a portfolio of interests, that the CEO wasn't active (with a PhD too) and attacking shareholders with defamatory comments - both on the board and in private messages in a most impertinent manner.
PSRU

Su Consulta Reciente

NASDAQ
RNAC
Cartesian Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados